You are here: Industry Insights > Fibromyalgia

News List

Tryp Therapeutics Receives Confirmation from FDA to Proceed with Phase 2a Study in Fibromyalgia AmericanPharmaceuticalReview
December 03, 2021
Tryp Therapeutics has received confirmation from the U.S. Food and Drug Administration ("FDA") that its review of Tryp's Investigational New Drug ("IND") application is complete and that the Company may proceed with its clinical study in fibromyalgia.
Four Weeks of Active TENS Beneficial for Fibromyalgia drugs
January 20, 2020
Four weeks of active transcutaneous electrical nerve stimulation (TENS) results in significant improvement in movement-evoked pain and other clinical outcomes compared with placebo-TENS or no TENS ...
Nerve Stimulation Therapy Could Cut Fibromyalgia Pain drugs
January 17, 2020
For people with the mysterious chronic pain condition fibromyalgia, researchers say nerve stimulation may offer some relief. In a recent study, use of TENS -- transcutaneous electrical nerve stimulation ...
Aptinyx’s NYX-2925 Demonstrates Positive Data in Fibromyalgia contractpharma
June 21, 2019
Phase 2 clinical study showed significant effects on both neuroimaging biomarkers and patient-reported outcomes, including pain scores.